Radiographic Bone Volume Alteration After Jaw Cyst Enucleation With Different Bone Grafts
Jaw Cysts
About this trial
This is an interventional treatment trial for Jaw Cysts
Eligibility Criteria
Inclusion Criteria:
- jaw bone cyst with the maximum diameter from 1.5cm to 4.0cm;
- focal teeth were preserved with root canal treatment;
- no previous surgical treatment of the cyst site;
- no evidence of acute inflammation;
- in good physical status and oral health;
- regular attendance at control visits.
Exclusion Criteria:
- pregnancy or lactation;
- aggregate systemic pathologies such as diabetes, thyroid disorders, bone metabolism diseases, among others;
- patients taking calcium, bisphosphonates, glucocorticoids, or other drugs that can interfere with bone metabolism;
- patients with uncontrolled periodontal conditions, endodontic conditions and other oral disorders;
- heavy smoke (10 cigarettes/day or more).
Sites / Locations
- Stomatology Hospital, Zhejiang University School of MedicineRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
No Intervention
Experimental
Experimental
Experimental
Control group
Collagen sponge group
GBR group
CS/GBR group
Patients in control group will be treated by cyst enucleation.
Cystic lesions in collagen sponge group will be filled by collagen sponge.
Cystic lesions in GBR group will be filled by deproteinized bovine substitute (DBBM, Bio-Oss®, granulometry 0.25-1 mm; Geistlich Pharma AG) and covered by absorbable collagen membrane (Bio-Gide®, Geistlich Pharma AG).
Cystic lesions in GBR group will be filled by collagen sponge and deproteinized bovine substitute (DBBM, Bio-Oss®, granulometry 0.25-1 mm; Geistlich Pharma AG) and covered by absorbable collagen membrane (Bio-Gide®, Geistlich Pharma AG).